WHO WE ARE
FCF is a specialized Investment Bank and Financing Specialist, advising public and private small/mid-market companies in the German speaking regions.
FCF focuses on four primary client segments:
- Mid-Markets: Medium-sized companies with sustainable business models in typical “Mittelstand” industries, such as industrial products and machinery, automotive, communications, logistics, and consumer products
- Real-Tech: R&D-driven companies in technology sectors, entering the commercialization stage with initial fast-growing revenues
- Growth: Fast growing companies, that have successfully entered their market, showing double digit revenue numbers and are seeking to expand widely
- Life Sciences: Highly innovative companies focusing on the development of cutting-edge biotechnology, med-tech, health-tech and pharmaceuticals solutions
FCF arranges, structures, and places equity and debt capital transactions and supports its clients’ growth, IPO/Pre-IPO, acquisition and standard balance sheet (re-)financing strategies at the best available terms.
Founded in 2005 and headquartered in Munich, FCF has direct relationships and works with all leading German, European and international/US financiers, lenders and investment houses addressing German small/mid-cap companies.
WHO WE SERVE
WHAT WE DO
(click below for details)
- with the best conditions,
- with the highest flexibility,
- in the shortest period of time,
- with the highest closing probability,
- with long-lasting financial partners that suit the company’s objectives.
- Deep knowledge and understanding of all relevant financial instruments across the debt and equity space:
- 360-degree perspective, offering maximum independence and freedom
- Complete financial markets insight with direct access to all relevant institutional investors and financiers
- Strategic approach in searching and selecting suitable investors
- Development, structuring and placing of comprehensive financial solutions combined with targeted financing measures
- The most creative team, specialized in the financing of SMEs
- Proactive, independent process management for strengthened negotiation leverage
- Focus on SMEs in the DACH region
- Quintessential medium-sized companies (“Mittelstand”) with revenues between EUR 100m and EUR 1,000m
- Fast growing companies operating established and proven business models
- Ultra-high growth, innovative companies with revolutionary technologies / products, for instance in life science and high-tech
- Access to & established network with the largest families, family offices and Ultra High Net Worth investors
- Discrete, bilateral discussions behind closed doors
- Direct investments with entrepreneurial and co-operative approach
- Long-term investment horizons all the way to evergreen funding
- Direct access to key executives at all top-tier and mid-sized investment banks
- to the market-leading, market-influencing sector experts
- to investment banking, capital markets and research departments
- Top-tier institutional US investors with focus on and interest in DACH enterprises
- Contact to selected “high profile” Ultra High Net Worth investors and family offices
- Exclusive dialog with the entrepreneurs / owners
- 100% focus on the requirements and interests
- Confidant and creative motivator in the decision-making process
- Maximization of alternative courses of action
RECENT TRANSACTIONS
Vasopharm GmbH
July 2019
Hydrogenious LOHC Technologies GmbH
July 2019
€ 17 million
Doppstadt Familienholding GmbH
June 2019
€ 80 million
Synapticon GmbH
June 2019
[amount confidential]
RECENT NEWS
Enno Spillner wird neuestes Mitglied im Life Science Advisory Board der FCF Fox Corporate Finance GmbH
München, 12. Dezember 2019 (fcf) – Enno Spillner wird neuestes Mitglied im Life Science Advisory Board der FCF Fox Corporate Finance GmbH Der Münchener Finanzierungsspezialist gewinnt für sein Life Science Advisory Board einen weiteren ausgewiesenen
Banken verschärfen Konditionen für Firmenkredite | Frankfurter Allgemeine FINANZEN 10/2019 – Gastbeitrag FCF
Nicht nur Privatleute, auch Unternehmen können sich so billig wie nie verschulden – allerdings nur, wenn ihre Bonität stimmt. Die Banken wollen genauer hinschauen, wem sie Geld leihen. Für deutsche Unternehmen ist es aktuell so
In Schwung bleiben – Finanzieren im Mittelstand | Süddeutsche Zeitung SPEZIAL 10/19 – Gastbeitrag von Arno Fuchs
Die konjunkturelle Abkühlung wirkt sich auch auf den Kreditmarkt aus. So sind die Zinsen für Firmenkredite bereits gestiegen. Experten raten Unternehmen derzeit, das aktuell noch günstige Finanzierungsumfeld zu nutzen. „Die Unternehmen sollten spätestens jetzt dringend